Brown Brothers Harriman & Co’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25
Closed -$15K 1255
2022
Q3
$15K Buy
+25
New +$15K ﹤0.01% 1048

Other funds holding AGL

Brown Brothers Harriman & Co's AGL Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of Agilon Health (AGL) in Q4 2022, closing a stake of 25 shares — an estimated $15K sold.

Brown Brothers Harriman & Co first reported a position in AGL in Q3 2022 and held it in 1 quarter. The position peaked at $15K in Q3 2022. 166 funds tracked by Wall St. Rank hold AGL as of Q4 2022.

  • Brown Brothers Harriman & Co reported no remaining Agilon Health position as of Q4 2022 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 25 Agilon Health shares in Q4 2022, an estimated $15K.
  • Brown Brothers Harriman & Co first reported a position in Agilon Health in Q3 2022 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's Agilon Health position peaked at $15K in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Agilon Health as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.